Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
15 February 2021 | Story Dr Cindé Greyling | Photo Charl Devenish
Quick and easy access to several health-care services under one roof. From the left, are Sister Sarien de Necker, Dr Arina Meyer, Dr Gerhard Jansen, Dr Elna Kleyn, and Sister Florence Maleho.


The University of the Free State Health Practice has been serving the UFS community for decades. Conveniently located on our Bloemfontein Campus, it offers quick and easy access to several health-care services under one roof. There is no need to struggle with your health or postpone check-ups – simply visit our UFS Health Practice for a pleasant experience. Our clientele ranges from UFS top management to staff/students with limited resources.

Several services and payment options

Over and above the general practitioner services, the physicians specialise in family health, travel medicine, and sport and exercise medicine. The practice also performs minor surgeries, treat non-sports related injuries, provide female health (PAP smears, contraception, etc.), and all blood tests. In addition, travellers can obtain vaccinations, and insurance policy examinations are also done. You can also get primary health care, physiotherapy, and biokinetic rehabilitation as part of the range of medical services offered at the UFS Health Practice. 

An appointment system limits the waiting time and walk-in emergencies are dealt with as needed. While the practice claims from medicals aids, UFS staff members have the option to deduct visiting costs from their salaries should their benefits be depleted. Non-medical aid patients can settle accounts by cash, card, or EFT. Students can also use their student accounts for doctor and physiotherapy visits within a capped amount. 

Convenient health care

The UFS Health Practice is open from Monday to Friday from 08:00 until 16:30, and mostly keep to its 15-minute consultation schedule, unless an emergency arises. Due to the unique setup, it can accommodate staff and student schedules, and the broader community is also welcome to make use of its services.

Dr Gerhard Jansen says quite a few staff members and their families are already visiting the practice, and they would love for more UFS employees to pay them a visit. “We are dedicated to our patients’ care and do regular follow-up calls to check on our patients’ health. When needed, we refer our patients for specialist care.”

For more information or to schedule an appointment, please:  
call: 051 401 2603/2530

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept